Google Chrome
Safari
Firefox
Edge
News / May 09, 2024
Hovione and iBET announce the creation of ViSync Technologies, an innovative new company that will develop solutions for unmet needs in cell and gene therapy
News release, 09 May 2024
Search
News / May 21, 2024
Hovione again ranks among best employers in Portugal
Hovione has placed fourth among the best companies to work in Portugal and was again the best in the Health Sector according to Randstad´s Employer Brand Research.
News / May 23, 2024
Diane Villax receives achievement award at Deloitte´s Investor Relations and Governance Awards (IRGAwards) 2024
36th edition of the Investor Relations & Governance Awards (IRGAwards) promoted by Deloitte
Press Clipping / Nov 23, 2023
Hovione Expands Technology Platforms with ExtremoChem Acquisition
Pharmaceutical Technology, 23 November 2023
News / Jun 14, 2024
Hovione launches new website for the Chinese Market
Hovione is closer to its customers with a new website in Mandarin
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
News / Jul 04, 2024
Hovione forges strategic partnership with Higuchi to further strengthen its presence in Japan
Hovione proudly announces its collaborative venture with Higuchi.
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / Oct 03, 2024
Hovione and Zerion Pharma create joint venture to further expand use of Dispersome® technology
A partnership to accelerate the development of the Dispersome® technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.